학술논문

Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib: Final ENESTcmr randomized trial results
Document Type
Letter
Source
In: Leukemia. (Leukemia, 1 November 2017, 31(11):2529-2531)
Subject
Language
English
ISSN
14765551
08876924